Genzyme First Phase of Job Cuts Will Eliminate 392 Positions

Genzyme Corp. said it implemented yesterday the first phase of a previously announced job cut program. The first phase will cut 392 positions, the company said in a regulatory filing.

To contact the editor responsible for this story: Bill Koenig at wkoenig@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.